Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
04/19/2005 | US6881566 Carbamoyl-phosphate synthetase gene of coryneform bacteria and method for producing L-arginine |
04/19/2005 | US6881565 Hydrolases; food processing; flavoring; soy sauce |
04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
04/19/2005 | US6881563 Human proteases and polynucleotides encoding the same |
04/19/2005 | US6881562 Proteases from gram-positive organisms |
04/19/2005 | US6881561 Endonuclease of immune cell, process for producing the same and immune adjuvant using the same |
04/19/2005 | US6881560 Introducing into a host, for expression of genes encoding enzymes required for synthesis of non-polyhydroxybutyrate and copolymer, a selected genes enzymes in combination of regulatory sequence to express the genes to encode enzymes |
04/19/2005 | US6881559 Enzymatic polypeptide for use as amplification tool in genetic engineering |
04/19/2005 | US6881555 AKT nucleic acids, polypeptides, and uses thereof |
04/19/2005 | US6881552 Human protease associated proteins |
04/19/2005 | US6881547 Identifying modulator which reduce collagen 4 domain polypeptides conformational isomers, autophosphorylation of goodpasture binding protein (GPBP) and treats goodpasture syndrome |
04/19/2005 | US6881546 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
04/19/2005 | US6881542 Comprises nucleotide sequences coding phosphorylating enzyme for diagnosis, prevention and treatment of cancer, diabetes, arthritis and hypertension |
04/19/2005 | US6881404 Enzymatic protein for treating inflammation, thrombosis andrestenosis |
04/19/2005 | US6881403 For prophylaxis and therapy of vaginal infections |
04/19/2005 | CA2312591C Poly adp-ribose polymerase gene and its uses |
04/19/2005 | CA2213223C Methods for maintaining sterility in plants |
04/19/2005 | CA2110497C Use of bacterial lipases for producing drugs for maldigestion therapy |
04/14/2005 | WO2005033313A2 Intracelluar trapping of radionuclides by enzyme-mediated reduction |
04/14/2005 | WO2005033311A2 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
04/14/2005 | WO2005033303A1 Mammalian cell lines modified for the production of recombinant glycoproteins |
04/14/2005 | WO2005033293A2 Hypoxia - responsive human cngh-0002 genes and polypeptides |
04/14/2005 | WO2005033286A2 Compositions and methods for synthesizing, purifying and detecting biomolecules |
04/14/2005 | WO2005033266A2 Regulation of acheron expression |
04/14/2005 | WO2005033145A1 Antibodies to nik, their preparation and use |
04/14/2005 | WO2005033142A2 Anti-nik antibodies and uses thereof |
04/14/2005 | WO2005033141A1 Regulation of matrix metalloproteinases by psp94 family members |
04/14/2005 | WO2005033140A1 Highly pure blood coagulation factor ix preparation and method of purifying the same |
04/14/2005 | WO2005033094A2 Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol |
04/14/2005 | WO2005032581A2 Hybrid molecules having factor vii/viia activity |
04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
04/14/2005 | WO2005032487A2 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
04/14/2005 | WO2005032258A1 Composition for lowering nitrate content in domesticated plant |
04/14/2005 | WO2005018579A3 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
04/14/2005 | WO2005017170A3 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
04/14/2005 | WO2005007864A3 Method for the production of carboxylic acid metal soaps |
04/14/2005 | WO2005007842A3 Crystal structure of cdp-me kinase and antimicrobal target |
04/14/2005 | WO2004113546A3 CASTANEA SATIVA MILL. GENES CODIFYING FOR ALLENE OXIDE CYCLASE, CYSTATIN, β-1,3-GLUCANASE AND THAUMATIN-LIKE PROTEIN AND THEIR USE |
04/14/2005 | WO2004101889A8 Use of hemicellulase composition in mechanical pulp production |
04/14/2005 | WO2004101739A3 Methods for chemically synthesizing immunoglobulin chimeric proteins |
04/14/2005 | WO2004083378A3 Mammalian cell lines specifically deficient in o-linked glycosylation |
04/14/2005 | WO2004072275A3 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge) |
04/14/2005 | WO2004042022A3 Kinases and phosphatases |
04/14/2005 | WO2004039955A3 Modulators of angiogenesis and tumorigenesis |
04/14/2005 | WO2004022764A9 Use of malate dehydrogenase for nadh regeneration |
04/14/2005 | WO2004015132A3 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives |
04/14/2005 | WO2004013347A3 Methods of identifying compounds that modulate protein activity |
04/14/2005 | WO2003106617A3 Methods of detecting and treating prostate cancer |
04/14/2005 | WO2003040340A3 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
04/14/2005 | WO2003025008A3 Bacterial polypeptides involved in protein processing |
04/14/2005 | US20050081267 Novel genes for conditional cell ablation |
04/14/2005 | US20050081265 Maize chloroplast protein synthesis elongation factors and methods of use for same |
04/14/2005 | US20050081264 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
04/14/2005 | US20050081263 Cholorophyllases |
04/14/2005 | US20050081260 nucleotide sequence or complements that code polypeptides having synthetase enzyme activity, used to alter enzyme levels in transformed host cells |
04/14/2005 | US20050081259 Using vector comprising nucleotide sequences coding protoporphyrinogen oxidase to transform chloroplast and generate herbicide resistant plants |
04/14/2005 | US20050080249 Genetic engineering; isolation polypeptides; heterogeneity amino acid sequences |
04/14/2005 | US20050080248 Multimeric oxidoreductases |
04/14/2005 | US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses |
04/14/2005 | US20050080232 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
04/14/2005 | US20050080140 Administering peroxisome proliferator-activated receptor (PPAR) delta agonist; a prostacyclin synthase gene or a protein encoded by the gene; rheumatoid arthritis, osteoarthritis, Crohn's disease, Guillain-Barre syndrome, skin disorders, post by-pass surgery restenosis, transplantation rejection |
04/14/2005 | US20050080027 Methods enabling the production yield of viral vectors derived from piroviruses to be improved by using DNA methylation inhibitors and/or Herpes viruses in the production of viral vectors derived from parvoviruses; suitable for transferring genes into mammalian cells, in particular into human cells |
04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
04/14/2005 | US20050080002 Methods for the treatment and prevention of cancer |
04/14/2005 | US20050079613 Downregulation of cell surface glycoproteins by a family of human ubiquitin ligases |
04/14/2005 | US20050079595 Expression vector comprising nucleotide sequences coding hydrolase for use in generating enantimorphic carboxylic acid; agrochemicals and pharmeceuticals; drug design |
04/14/2005 | US20050079593 Modified enzymes having polymer conjugates |
04/14/2005 | US20050079586 Enzymatic polypeptide for use as tool in production of D-ribulose-5-phosphate in bacteria; bioreactors |
04/14/2005 | US20050079585 Complement depletion using recombinant human C3-derivatives |
04/14/2005 | US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
04/14/2005 | US20050079573 Proteins |
04/14/2005 | US20050079567 Modified luciferase |
04/14/2005 | US20050079558 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
04/14/2005 | US20050079530 Novel human kinase proteins and polynucleotides encoding the same |
04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
04/14/2005 | US20050079498 Expression vector comprising nucleotide sequences coding polypeptide associated with clavam compounds for use in transformation and generation of cells with improved clavulanic acid production |
04/14/2005 | CA2776997A1 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
04/14/2005 | CA2545639A1 Regulation of matrix metalloproteinases by psp94 family members |
04/14/2005 | CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
04/14/2005 | CA2541535A1 Antibodies to nik, their preparation and use |
04/14/2005 | CA2540875A1 Compositions and processes for genotyping single nucleotide polymorphisms |
04/14/2005 | CA2540521A1 Anti-nik antibodies and uses thereof |
04/14/2005 | CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them |
04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
04/13/2005 | EP1522586A1 Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme |
04/13/2005 | EP1522584A2 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
04/13/2005 | EP1522582A2 Optical sorting method |
04/13/2005 | EP1522581A2 Optical sortingmethod |
04/13/2005 | EP1522580A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
04/13/2005 | EP1522579A2 Hyaluronan synthase gene and uses thereof |
04/13/2005 | EP1522543A1 Use Steroid sulphatase inhibitors for the manufacture of a medicament for the treatment of an oestrogen dependent tumour |
04/13/2005 | EP1521842A1 Electrochemical sensing using an enzyme electrode |
04/13/2005 | EP1521836A2 Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof |
04/13/2005 | EP1521835A1 Use of ahas mutant genes as selection marker in potato transformation |
04/13/2005 | EP1521834A1 Use of a gene for increasing the oil content in plants |
04/13/2005 | EP1521833A2 Synthetic herbicide resistance gene |
04/13/2005 | EP1521827A1 Modulation of cytochrome p450 reductase activity |